US5250022A
(en)
*
|
1990-09-25 |
1993-10-05 |
Rutgers, The State University Of New Jersey |
Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5679399A
(en)
*
|
1987-07-17 |
1997-10-21 |
Bio Barrier, Inc. |
Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
|
US5549924A
(en)
*
|
1987-07-17 |
1996-08-27 |
Robin Renee Thill Shlenker |
Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
|
US5496266A
(en)
*
|
1990-04-30 |
1996-03-05 |
Alza Corporation |
Device and method of iontophoretic drug delivery
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US4927408A
(en)
*
|
1988-10-03 |
1990-05-22 |
Alza Corporation |
Electrotransport transdermal system
|
US5147296A
(en)
*
|
1988-10-03 |
1992-09-15 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5240995A
(en)
*
|
1989-02-09 |
1993-08-31 |
Alza Corporation |
Electrotransport adhesive
|
US5234992A
(en)
*
|
1989-02-09 |
1993-08-10 |
Alza Corporation |
Electrotransport adhesive
|
JP2865422B2
(ja)
*
|
1989-10-23 |
1999-03-08 |
セラテック,インコーポレイテッド |
イオン浸透療法装置および速度調整膜を用いた方法
|
JP2816886B2
(ja)
*
|
1990-03-05 |
1998-10-27 |
興和株式会社 |
生体通電装置
|
GR1000433B
(el)
*
|
1990-04-24 |
1992-07-30 |
Alza Corp |
Συσκευη και μεθοδος ιοντοφορητικης απελευθερωσης φαρμακου.
|
US5147297A
(en)
*
|
1990-05-07 |
1992-09-15 |
Alza Corporation |
Iontophoretic delivery device
|
US5362308A
(en)
*
|
1990-09-25 |
1994-11-08 |
Rutgers, The State University Of New Jersey |
Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
|
US5677360A
(en)
*
|
1991-02-13 |
1997-10-14 |
Mitsubishi Rayon Co., Ltd. |
Hydrophilic polymer alloy, fiber and porous membrane comprising this polymer alloy, and methods for preparing them
|
US5405317A
(en)
*
|
1991-05-03 |
1995-04-11 |
Alza Corporation |
Iontophoretic delivery device
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
US5356632A
(en)
*
|
1991-09-12 |
1994-10-18 |
S.I. Scientific Innovations Ltd. |
Transdermal drug delivery device
|
SE9102778D0
(sv)
*
|
1991-09-25 |
1991-09-25 |
Siemens Elema Ab |
Implanterbar medicinsk anordning
|
US5421816A
(en)
*
|
1992-10-14 |
1995-06-06 |
Endodermic Medical Technologies Company |
Ultrasonic transdermal drug delivery system
|
CA2126487C
(en)
*
|
1993-06-23 |
2001-05-29 |
Keiichiro Okabe |
Iontophoresis device
|
US5387189A
(en)
*
|
1993-12-02 |
1995-02-07 |
Alza Corporation |
Electrotransport delivery device and method of making same
|
US5508262A
(en)
*
|
1993-12-15 |
1996-04-16 |
University Of South Florida |
Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
|
WO1995027530A1
(en)
*
|
1994-04-08 |
1995-10-19 |
Alza Corporation |
Electrotransport system with ion exchange competitive ion capture
|
FR2719485B1
(fr)
*
|
1994-05-06 |
1996-07-12 |
Lhd Lab Hygiene Dietetique |
Procédé et dispositif de mesure de la quantité d'un principe actif contenu dans un réservoir.
|
JP3523334B2
(ja)
*
|
1994-07-02 |
2004-04-26 |
久光製薬株式会社 |
イオントフォレ−シス用プラスター構造体
|
US5861439A
(en)
*
|
1994-11-14 |
1999-01-19 |
Alza Corporation |
Method for enhanced electrotransport agent delivery
|
FR2726769B1
(fr)
*
|
1994-11-16 |
1997-01-31 |
Lhd Lab Hygiene Dietetique |
Dispositif ionophoretique d'administration transdermique de medicaments et ensemble jetable formant partie d'un tel dispositif
|
US5855867A
(en)
*
|
1995-03-29 |
1999-01-05 |
The Curators Of The University Of Missouri |
Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
IL113459A
(en)
*
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
WO2000023144A1
(en)
*
|
1995-04-23 |
2000-04-27 |
Electromagnetic Bracing Systems, Inc. |
Transdermal active drug delivery system and method
|
US5853383A
(en)
*
|
1995-05-03 |
1998-12-29 |
Alza Corporation |
Preparation for formulations for electrotransport drug delivery
|
IE960375A1
(en)
*
|
1995-06-05 |
1996-12-11 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6216033B1
(en)
|
1996-05-22 |
2001-04-10 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
ES2218586T3
(es)
*
|
1995-06-05 |
2004-11-16 |
Alza Corporation |
Dispositivo de administracion transdermica de fentanil y de sufentanil por electrotransporte.
|
US5747453A
(en)
|
1995-06-06 |
1998-05-05 |
Alza Corporation |
Method for increasing the electrotransport flux of polypeptides
|
US5983130A
(en)
|
1995-06-07 |
1999-11-09 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US7572252B1
(en)
|
1995-06-07 |
2009-08-11 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US5767084A
(en)
*
|
1995-10-06 |
1998-06-16 |
The Curators Of The University Of Missouri |
Method of treatment for cystic fibrosis and peptides for same
|
WO1997017091A1
(en)
|
1995-11-08 |
1997-05-15 |
University Of South Florida |
Guinea pig model for leiomyomas and atherosclerosis
|
DE69733268T2
(de)
|
1996-01-30 |
2006-01-19 |
Novagent Oy |
Zusammensetzung für die kontrollierte Freisetzung eines Arzneimittels bei der transdermalen Verabreichung
|
US6333189B1
(en)
|
1996-06-06 |
2001-12-25 |
Alza Corporation |
Method of making an electrotransport device
|
US6718201B1
(en)
|
1996-06-07 |
2004-04-06 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
DE69719761T2
(de)
*
|
1996-06-18 |
2003-12-18 |
Alza Corp |
Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
|
WO1997048443A1
(en)
*
|
1996-06-19 |
1997-12-24 |
Becton Dickinson And Company |
Iontophoretic delivery of cell adhesion inhibitors
|
EP0813887A3
(de)
*
|
1996-06-20 |
1999-11-03 |
Hisamitsu Pharmaceutical Co. Inc. |
Iontophoretische Vorrichtung
|
US5857993A
(en)
*
|
1996-07-12 |
1999-01-12 |
Empi, Inc. |
Process of making an iontophoresis electrode
|
US5941843A
(en)
*
|
1996-07-12 |
1999-08-24 |
Empi, Inc. |
Iontophoresis electrode
|
US5871461A
(en)
*
|
1996-07-12 |
1999-02-16 |
Empi, Inc. |
Method of making an iontophoresis electrode
|
US6350259B1
(en)
*
|
1996-09-30 |
2002-02-26 |
Vyteris, Inc. |
Selected drug delivery profiles using competing ions
|
US5906976A
(en)
*
|
1996-10-22 |
1999-05-25 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Method and composition for treating neuronal degeneration
|
FR2755372B1
(fr)
*
|
1996-11-07 |
1998-12-24 |
Elf Aquitaine |
Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
|
US6650934B2
(en)
|
1996-12-17 |
2003-11-18 |
Alza Corp |
Polymeric foam reservoirs for an electrotransport delivery device
|
US6246904B1
(en)
|
1996-12-17 |
2001-06-12 |
Alza Corporation |
Electrotransport drug delivery reservoirs containing inert fillers
|
US6119036A
(en)
*
|
1997-03-26 |
2000-09-12 |
The Board Of Regents Of The University Of Oklahoma |
Iontophoretic transdermal delivery device
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US6004577A
(en)
*
|
1997-08-12 |
1999-12-21 |
Murdock; Thomas O. |
Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
|
US6775569B2
(en)
*
|
1997-11-05 |
2004-08-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Electroporation device for in vivo delivery of therapeutic agents
|
CA2309955A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Alza Corporation |
Method for decreasing self-association of polypeptides
|
JP3980140B2
(ja)
*
|
1997-12-04 |
2007-09-26 |
村越 寧根 |
治療器具
|
US6918901B1
(en)
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
PT1037686E
(pt)
*
|
1997-12-11 |
2005-10-31 |
Alza Corp |
Aparelho para potenciar o fluxo de agente transdermico
|
EP1911488A3
(de)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
|
ATE221400T1
(de)
*
|
1997-12-11 |
2002-08-15 |
Alza Corp |
Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
|
CN1206004C
(zh)
|
1997-12-11 |
2005-06-15 |
阿尔扎有限公司 |
增强透皮物剂流量的装置
|
US6163720A
(en)
*
|
1997-12-18 |
2000-12-19 |
Alza Corporation |
Layered rate controlling membranes for use in an electrotransport device
|
US6374136B1
(en)
*
|
1997-12-22 |
2002-04-16 |
Alza Corporation |
Anhydrous drug reservoir for electrolytic transdermal delivery device
|
JP4154017B2
(ja)
*
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6489306B2
(en)
|
1998-02-23 |
2002-12-03 |
University Of South Florida |
Method of intranasal gene transfer for protection against respiratory infection
|
US6028102A
(en)
*
|
1998-02-24 |
2000-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticonvulsant drugs and pharmaceutical compositions thereof
|
US6059736A
(en)
*
|
1998-02-24 |
2000-05-09 |
Tapper; Robert |
Sensor controlled analysis and therapeutic delivery system
|
US6338834B1
(en)
|
1998-04-30 |
2002-01-15 |
The Curators Of The University Of Missouri |
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
AU4994899A
(en)
|
1998-07-13 |
2000-02-01 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
AU5329599A
(en)
*
|
1998-07-30 |
2000-02-21 |
University Of South Florida |
Method for the modulation of function of transcription factors
|
US6780397B2
(en)
|
1998-09-01 |
2004-08-24 |
Curators Of The University Of Missouri |
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
|
US20050171021A1
(en)
*
|
1998-11-12 |
2005-08-04 |
Cormier Michel J. |
Buffered drug formulations for transdermal
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
US6638974B1
(en)
|
1999-04-09 |
2003-10-28 |
University Of South Florida |
Ascorbyl esters for the treatment of cancer
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
EP1233670B1
(de)
*
|
1999-06-14 |
2008-09-17 |
Henry Ford Health System |
Stickstoffmonoxid-donoren zum induzieren von neurogenese
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US6394994B1
(en)
*
|
1999-08-27 |
2002-05-28 |
Vyteris, Inc. |
Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
AU4710401A
(en)
|
1999-12-02 |
2001-06-18 |
University Of South Florida |
Method and composition for treatment of ischemic neuronal reperfusion injury
|
DE60024312T2
(de)
|
1999-12-10 |
2006-08-17 |
Alza Corp., Mountain View |
Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
|
AU2002218744A1
(en)
*
|
2000-07-11 |
2002-01-21 |
University Of South Florida |
Bax fragment induced tumor cell death
|
FR2812218B1
(fr)
*
|
2000-07-28 |
2003-01-10 |
Eastman Kodak Co |
Procede pour ameliorer le fonctionnement d'une membrane d'un dispositif de nanofiltration
|
US6803060B2
(en)
|
2000-09-07 |
2004-10-12 |
Joe Reyes |
Composition to boost libido
|
US20070025958A1
(en)
*
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US20060194242A1
(en)
*
|
2000-10-27 |
2006-08-31 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
JP2004521867A
(ja)
*
|
2000-10-27 |
2004-07-22 |
イミュノ−アールエックス, インコーポレイテッド |
免疫抑制された患者のためのワクチン免疫療法
|
US6553255B1
(en)
|
2000-10-27 |
2003-04-22 |
Aciont Inc. |
Use of background electrolytes to minimize flux variability during iontophoresis
|
US7182942B2
(en)
*
|
2000-10-27 |
2007-02-27 |
Irx Therapeutics, Inc. |
Vaccine immunotherapy for immune suppressed patients
|
WO2002081024A1
(en)
*
|
2001-04-04 |
2002-10-17 |
Alza Corporation |
Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
CA2498591A1
(en)
*
|
2001-10-26 |
2003-05-01 |
Immuno-Rx, Inc. |
Immunotherapy for reversing immune suppression
|
US7349733B2
(en)
|
2001-11-02 |
2008-03-25 |
Ceramatel, Inc. |
Iontophoretic drug delivery systems
|
US7047069B2
(en)
|
2002-02-04 |
2006-05-16 |
Ceramatec, Inc. |
Iontophoretic fluid delivery device
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
DE10205373B4
(de)
*
|
2002-02-09 |
2007-07-19 |
Aloys Wobben |
Brandschutz
|
CA2500713C
(en)
*
|
2002-10-04 |
2012-07-03 |
Photokinetix, Inc. |
Photokinetic delivery of biologically active substances using pulsed incoherent light
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
US6872292B2
(en)
*
|
2003-01-28 |
2005-03-29 |
Microlin, L.C. |
Voltage modulation of advanced electrochemical delivery system
|
US7220778B2
(en)
*
|
2003-04-15 |
2007-05-22 |
The General Hospital Corporation |
Methods and devices for epithelial protection during photodynamic therapy
|
BRPI0413354A
(pt)
*
|
2003-08-04 |
2006-10-10 |
Alza Corp |
método e dispositivo para intensificar fluxo de agente transdérmico
|
EP1662879A4
(de)
*
|
2003-08-29 |
2009-03-11 |
Univ New York |
Indirekte abgabe von wachstumsfaktoren in das zentrale nervensystem
|
CA2538904C
(en)
*
|
2003-09-12 |
2013-03-12 |
Paul Wischmeyer |
Glutamine for use in treating injury
|
US20050089554A1
(en)
*
|
2003-10-24 |
2005-04-28 |
Cormier Michel J. |
Apparatus and method for enhancing transdermal drug delivery
|
US20050106226A1
(en)
*
|
2003-10-24 |
2005-05-19 |
Cormier Michel J. |
Pretreatment method and system for enhancing transdermal drug delivery
|
CN1897883A
(zh)
*
|
2003-10-28 |
2007-01-17 |
阿尔扎公司 |
通过涂覆的微喷射体释放治疗用肽和蛋白的聚合物缀合物
|
MXPA06005509A
(es)
*
|
2003-11-13 |
2007-05-23 |
Johnson & Johnson |
Sistema y metodo para distribucion transdermica.
|
CA2546399A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Alza Corporation |
Methods for preparing polymeric buffer formulations for electrotransport applications
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
WO2005062718A2
(en)
*
|
2003-12-30 |
2005-07-14 |
Syndromex Ltd. |
Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid
|
EP1758998B1
(de)
|
2004-01-30 |
2010-12-15 |
Quark Pharmaceuticals, Inc. |
Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
|
US20050220439A1
(en)
*
|
2004-03-19 |
2005-10-06 |
Carton Owen A |
Interactive multimedia system and method
|
JP2007532645A
(ja)
*
|
2004-04-13 |
2007-11-15 |
アルザ コーポレイション |
フェンタニルに基づく薬剤の経皮送達システム用の器具および方法
|
AU2005244734A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
JP2008507590A
(ja)
*
|
2004-05-19 |
2008-03-13 |
アルザ コーポレイション |
免疫活性剤を経皮送達するための方法及び配合物
|
US20060030811A1
(en)
*
|
2004-08-03 |
2006-02-09 |
Wong Patrick S |
Method and device for enhancing transdermal agent flux
|
AR054300A1
(es)
*
|
2004-08-10 |
2007-06-20 |
Alza Corp |
Aparato y sistema de microproyeccion con escaso potencial infeccioso
|
CN101123994B
(zh)
|
2004-08-16 |
2012-11-14 |
夸克医药公司 |
Rtp801的抑制剂的治疗性用途
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
MX2007003795A
(es)
|
2004-09-28 |
2007-07-11 |
Quark Biotech Inc |
Oligoribonucleotidos y metodos de uso de los mismos para tratamiento de la alopecia, insuficiencia renal aguda y otras enfermedades.
|
JP2006116086A
(ja)
*
|
2004-10-21 |
2006-05-11 |
Tokuyama Corp |
イオントフォレーシス装置用作用極構造体及びイオントフォレーシス装置
|
US20060095001A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Transcutaneous Technologies Inc. |
Electrode and iontophoresis device
|
WO2006055729A1
(en)
*
|
2004-11-16 |
2006-05-26 |
Transcutaneous Technologies Inc. |
Iontophoretic device and method for administering immune response-enhancing agents and compositions
|
JP4728631B2
(ja)
*
|
2004-11-30 |
2011-07-20 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
AU2005312736A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Tti Ellebeau, Inc. |
Ion-tophoretic apparatus
|
US7590444B2
(en)
*
|
2004-12-09 |
2009-09-15 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
JP4731931B2
(ja)
*
|
2005-02-03 |
2011-07-27 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
CA2595990A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
EP1853231A2
(de)
*
|
2005-02-16 |
2007-11-14 |
Alza Corporation |
Vorrichtung und verfahren zur transdermalen zuführung von agentien auf erythropoetin-basis
|
JP2008529750A
(ja)
*
|
2005-02-16 |
2008-08-07 |
アルザ コーポレイション |
生体適合性が改善されたマイクロプロジェクションアレイ
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
JP4793806B2
(ja)
|
2005-03-22 |
2011-10-12 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
JP2006296511A
(ja)
*
|
2005-04-15 |
2006-11-02 |
Transcutaneous Technologies Inc |
外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
|
CN101189031A
(zh)
*
|
2005-06-02 |
2008-05-28 |
阿尔扎公司 |
透皮递送器械的最终消毒方法
|
JP2006334164A
(ja)
*
|
2005-06-02 |
2006-12-14 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその制御方法
|
US20060280645A1
(en)
*
|
2005-06-02 |
2006-12-14 |
Scott Sellers |
Method for terminal sterilization of transdermal delivery devices
|
JP2006346368A
(ja)
*
|
2005-06-20 |
2006-12-28 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその製造方法
|
JP2007000342A
(ja)
*
|
2005-06-23 |
2007-01-11 |
Transcutaneous Technologies Inc |
複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
|
JPWO2007010900A1
(ja)
*
|
2005-07-15 |
2009-01-29 |
Tti・エルビュー株式会社 |
貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
|
KR100719095B1
(ko)
*
|
2005-07-29 |
2007-05-17 |
성균관대학교산학협력단 |
연료 확산속도 제어물질층을 포함하여 메탄올 크로스오버현상을 억제시킨 직접 메탄올 연료전지
|
US8386030B2
(en)
*
|
2005-08-08 |
2013-02-26 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US8295922B2
(en)
|
2005-08-08 |
2012-10-23 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US20070088332A1
(en)
*
|
2005-08-22 |
2007-04-19 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
US20090254018A1
(en)
*
|
2005-08-24 |
2009-10-08 |
Mizuo Nakayama |
Electrode assembly for freezing-type iontophoresis device
|
WO2007026672A1
(ja)
*
|
2005-08-29 |
2007-03-08 |
Transcu Ltd. |
イオントフォレーシス用汎用性電解液組成物
|
WO2007029611A1
(ja)
*
|
2005-09-06 |
2007-03-15 |
Tti Ellebeau, Inc. |
イオントフォレーシス装置
|
US20070112294A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
WO2007032446A1
(ja)
|
2005-09-15 |
2007-03-22 |
Tti Ellebeau, Inc. |
ロッド型イオントフォレーシス装置
|
RU2008114830A
(ru)
*
|
2005-09-16 |
2009-10-27 |
ТиТиАй ЭЛЛЕБО, ИНК. (JP) |
Устройство ионтофореза катетерного типа
|
WO2007038028A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Tti Ellebeau, Inc. |
Iontophoresis apparatus and method to deliver active agents to biological interfaces
|
US20090299264A1
(en)
*
|
2005-09-28 |
2009-12-03 |
Tti Ellebeau, Inc. |
Electrode Assembly for Dry Type Iontophoresis
|
KR20080080087A
(ko)
*
|
2005-09-30 |
2008-09-02 |
티티아이 엘뷰 가부시키가이샤 |
신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
|
US20070135754A1
(en)
*
|
2005-09-30 |
2007-06-14 |
Hidero Akiyama |
Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
|
US20090299265A1
(en)
*
|
2005-09-30 |
2009-12-03 |
Tti Ellebeau, Inc. |
Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
|
JP2009509677A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Tti・エルビュー株式会社 |
小胞封入活性物質のイオントフォレーシス送達
|
WO2007041118A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Iontophoretic device and method of delivery of active agents to biological interface
|
WO2007041115A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau Inc. |
Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
|
WO2007041543A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Iontophoresis device to deliver multiple active agents to biological interfaces
|
WO2007037476A1
(ja)
*
|
2005-09-30 |
2007-04-05 |
Tti Ellebeau, Inc. |
睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
WO2007038555A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Tti Ellebeau, Inc. |
Iontophoretic device and method of delivery of active agents to biological interface
|
US20070197955A1
(en)
*
|
2005-10-12 |
2007-08-23 |
Transcutaneous Technologies Inc. |
Mucous membrane adhesion-type iontophoresis device
|
WO2007079116A1
(en)
*
|
2005-12-28 |
2007-07-12 |
Tti Ellebeau, Inc. |
Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
|
EP1965858A2
(de)
*
|
2005-12-30 |
2008-09-10 |
Tti Ellebeau, Inc. |
System und verfahren zur fernsteuerung eines iontophoresegerätes
|
EP1965856A2
(de)
*
|
2005-12-30 |
2008-09-10 |
Tti Ellebeau, Inc. |
Iontophoretische systeme, vorrichtungen und verfahren zur abgabe von wirkstoffen an eine biologische schnittstelle
|
EP1981910B1
(de)
|
2006-01-13 |
2013-06-26 |
A Chan Holding B.V. |
Verfahren zur identifikation von einem inhibitor der wechselwirkung zwischen glypican und sclerostin
|
NL2000439C2
(nl)
|
2006-01-20 |
2009-03-16 |
Quark Biotech |
Therapeutische toepassingen van inhibitoren van RTP801.
|
CN101466393A
(zh)
*
|
2006-03-15 |
2009-06-24 |
阿尔扎公司 |
用于经皮递送甲状旁腺激素药剂以治疗骨质减少的方法
|
WO2007123707A1
(en)
*
|
2006-03-30 |
2007-11-01 |
Tti Ellebeau, Inc. |
Controlled release membrane and methods of use
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
MX2009002321A
(es)
*
|
2006-09-05 |
2009-03-23 |
Tti Ellebeau Inc |
Sistemas, dispositivos y metodos de suministro transdermico de farmacos que utilizan suministros de energia inductiva.
|
MX2009002320A
(es)
|
2006-09-05 |
2009-03-23 |
Tti Ellebeau Inc |
Sistemas, dispositivos y metodos no destructivos para evaluar dispositivos de suministro de farmacos mediante iontoforesis.
|
BRPI0716450A2
(pt)
|
2006-09-05 |
2014-03-11 |
Tti Ellebeau Inc |
Sistemas, dispositivos e métodos de impedância para avaliar propriedades iontoforéticas de compostos
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
JP5383497B2
(ja)
|
2006-12-01 |
2014-01-08 |
Tti・エルビュー株式会社 |
装置、例として経皮送達装置に給電し且つ/又は当該装置を制御するシステム及び装置
|
JPWO2008087884A1
(ja)
|
2007-01-16 |
2010-05-06 |
Tti・エルビュー株式会社 |
薬物投与量の予測方法及びそのプログラム
|
US20080188791A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Difiore Attilio E |
Active iontophoresis delivery system
|
EP2157970A1
(de)
*
|
2007-05-18 |
2010-03-03 |
Tti Ellebeau, Inc. |
Transdermale freisetzungsvorrichtungen für verbesserte freisetzung eines wirkstoffes durch eine biologische schnittstelle
|
US8197844B2
(en)
*
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
WO2010008822A2
(en)
|
2008-06-23 |
2010-01-21 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
|
US8729121B2
(en)
|
2007-06-25 |
2014-05-20 |
Adhezion Biomedical, Llc |
Curing accelerator and method of making
|
CA2724949A1
(en)
*
|
2007-06-27 |
2008-12-31 |
The General Hospital Corporation |
Method and apparatus for optical inhibition of photodynamic therapy
|
ES2474176T3
(es)
|
2007-06-27 |
2014-07-08 |
Quark Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir la expresión de genes pro-apopt�ticos
|
CN101815521B
(zh)
|
2007-10-03 |
2014-12-10 |
夸克制药公司 |
新siRNA结构
|
US8613952B2
(en)
|
2007-11-14 |
2013-12-24 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
EP2106791A1
(de)
|
2008-03-31 |
2009-10-07 |
Biotempt B.V. |
Glutamin oder Glutamine enthaltendes Dipeptide in einer spezifischen Dosierung für die Behandlung von Entzündungen
|
CA2727015A1
(en)
*
|
2008-06-04 |
2009-12-10 |
Coda Therapeutics, Inc. |
Treatment of pain with gap junction modulation compounds
|
US8198344B2
(en)
|
2008-06-20 |
2012-06-12 |
Adhezion Biomedical, Llc |
Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
|
US8293838B2
(en)
|
2008-06-20 |
2012-10-23 |
Adhezion Biomedical, Llc |
Stable and sterile tissue adhesive composition with a controlled high viscosity
|
BRPI0918060A2
(pt)
*
|
2008-09-10 |
2015-12-01 |
Transcu Ltd |
aparelho e método de distribuição de líquidos viscosos a base de hpc em substratos porosos, por exemplo, processo contínuo a base de tecido.
|
US8609128B2
(en)
|
2008-10-31 |
2013-12-17 |
Adhezion Biomedical, Llc |
Cyanoacrylate-based liquid microbial sealant drape
|
US8652510B2
(en)
|
2008-10-31 |
2014-02-18 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
US9254133B2
(en)
|
2008-10-31 |
2016-02-09 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
WO2010080452A2
(en)
|
2008-12-18 |
2010-07-15 |
Quark Pharmaceuticals, Inc. |
siRNA COMPOUNDS AND METHODS OF USE THEREOF
|
US9008765B2
(en)
|
2009-02-12 |
2015-04-14 |
Incube Labs, Llc |
System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
|
US8190252B2
(en)
|
2009-02-12 |
2012-05-29 |
Incube Labs, Llc |
Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
|
US8961492B2
(en)
|
2009-02-12 |
2015-02-24 |
Incube Labs, Llc |
System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
|
KR101674904B1
(ko)
|
2009-02-26 |
2016-11-10 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
중재형 약물전달 시스템과 그 방법
|
CN102387812A
(zh)
|
2009-03-26 |
2012-03-21 |
亨利福特保健系统公司 |
神经损伤和神经退行性疾病后改善神经学预后的方法
|
US20110092881A1
(en)
*
|
2009-05-08 |
2011-04-21 |
Isis Biopolymer Inc. |
Iontophoretic device with contact sensor
|
EP2427245A1
(de)
*
|
2009-05-08 |
2012-03-14 |
Isis Biopolymer, Inc. |
Iontophorese-vorrichtung mit verbesserter gegenelektrode
|
DK3276004T3
(da)
|
2009-06-08 |
2020-04-06 |
Quark Pharmaceuticals Inc |
Fremgangsmåder til behandling af kronisk nyresygdom
|
EP2440694A4
(de)
*
|
2009-06-09 |
2012-12-19 |
Tti Ellebeau Inc |
Langlebige elektrode von hoher kapazität und herstellungsverfahren dafür
|
WO2011044175A2
(en)
|
2009-10-06 |
2011-04-14 |
Incube Labs, Llc |
Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
|
TW201124160A
(en)
|
2009-11-26 |
2011-07-16 |
Quark Pharmaceuticals Inc |
SiRNA compounds comprising terminal substitutions
|
US8685038B2
(en)
|
2009-12-07 |
2014-04-01 |
Incube Labs, Llc |
Iontophoretic apparatus and method for marking of the skin
|
EP2862929B1
(de)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Zusammensetzungen und Verfahren zur Behandlung von Erkrankungen, Störungen oder Läsionen des ZNS
|
KR101692063B1
(ko)
|
2009-12-09 |
2017-01-03 |
닛토덴코 가부시키가이샤 |
hsp47 발현의 조절
|
JP5463136B2
(ja)
*
|
2009-12-22 |
2014-04-09 |
帝國製薬株式会社 |
イオントフォレーシス療法に用いる電極装置
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
WO2011100376A2
(en)
|
2010-02-10 |
2011-08-18 |
Incube Labs, Llc |
Methods and architecture for power optimization of iontophoretic transdermal drug delivery
|
JP2013520444A
(ja)
|
2010-02-22 |
2013-06-06 |
ヘルス エンハンスメント プロダクツ インコーポレイテッド |
高コレステロール血症を処置するための薬剤及び機序
|
KR20130073893A
(ko)
|
2010-04-13 |
2013-07-03 |
나지브 바불 |
1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
|
US9309019B2
(en)
|
2010-05-21 |
2016-04-12 |
Adhezion Biomedical, Llc |
Low dose gamma sterilization of liquid adhesives
|
US9045755B2
(en)
|
2010-06-24 |
2015-06-02 |
Quark Pharmaceuticals, Inc. |
Double stranded RNA compounds to RhoA and use thereof
|
US20140134231A1
(en)
|
2010-10-11 |
2014-05-15 |
Sanford-Burnham Medical Research Institute |
Mir-211 expression and related pathways in human melanoma
|
US20130324591A1
(en)
|
2010-12-06 |
2013-12-05 |
Quark Pharmaceuticals, Inc. |
Double stranded oligonucleotide compounds comprising positional modifications
|
JP6132775B2
(ja)
|
2011-03-03 |
2017-05-24 |
クォーク ファーマシューティカルズ インコーポレーティッドQuark Pharmaceuticals,Inc. |
Toll様受容体経路のオリゴヌクレオチド修飾因子
|
US9796979B2
(en)
|
2011-03-03 |
2017-10-24 |
Quark Pharmaceuticals Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
WO2012118910A2
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating lung disease and injury
|
EP3626304A1
(de)
|
2011-03-24 |
2020-03-25 |
Incube Labs, Llc |
System und verfahren zur zweiphasigen transdermalen iontophoretischen abgabe von therapiemitteln
|
US8781571B2
(en)
|
2011-03-31 |
2014-07-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US9731121B2
(en)
|
2011-03-31 |
2017-08-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US8428709B1
(en)
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
CN104080912A
(zh)
|
2012-01-12 |
2014-10-01 |
夸克制药公司 |
用于治疗听力和平衡障碍的组合疗法
|
EP3269372B1
(de)
|
2012-01-19 |
2019-06-12 |
Hybrid Medical, LLC |
Topische therapeutische formulierungen
|
US9314571B1
(en)
*
|
2012-02-10 |
2016-04-19 |
Mphase Technologies, Inc. |
Drug delivery system
|
EP2831233A1
(de)
|
2012-03-27 |
2015-02-04 |
CoDa Therapeutics, Inc. |
Zusammensetzungen und behandlungen auf der basis von cadherin-modulation
|
NZ701949A
(en)
|
2012-05-18 |
2016-07-29 |
Otago Innovation Ltd |
Combination treatments and compositions for wound healing
|
JP6202287B2
(ja)
|
2012-05-23 |
2017-09-27 |
セリックスビオ プライヴェート リミテッド |
炎症性腸疾患の治療のための組成物及び方法
|
JP2015518854A
(ja)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
多発性硬化症の治療のための組成物および方法
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
US20130323222A1
(en)
|
2012-06-04 |
2013-12-05 |
Matthew Charles |
Human tissue kallikrein 1 glycosylation isoforms
|
US9421245B2
(en)
|
2012-06-25 |
2016-08-23 |
The Brigham And Women's Hospital, Inc. |
Targeted therapeutics
|
EP2895608B1
(de)
|
2012-09-12 |
2018-12-05 |
Quark Pharmaceuticals, Inc. |
Doppelsträngige oligonukleotidmoleküle an p53 und verfahren zur verwendung davon
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
JP6364009B2
(ja)
|
2012-09-12 |
2018-07-25 |
クォーク ファーマシューティカルズ インコーポレーティッドQuark Pharmaceuticals,Inc. |
P53に対する二本鎖オリゴヌクレオチド分子、およびその使用方法
|
JP6154025B2
(ja)
|
2012-12-24 |
2017-06-28 |
ニューロガストルクス,インコーポレイテッド |
Gi管障害を治療するための方法
|
WO2014164981A1
(en)
|
2013-03-12 |
2014-10-09 |
The General Hospital Corporation |
Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
|
WO2014201372A1
(en)
|
2013-06-13 |
2014-12-18 |
Health Enhancement Products, Inc. |
Compounds and methods for affecting cytokines
|
WO2015020960A1
(en)
|
2013-08-09 |
2015-02-12 |
Novartis Ag |
Novel lncrna polynucleotides
|
WO2015040049A1
(en)
*
|
2013-09-19 |
2015-03-26 |
Koninklijke Philips N.V. |
Treatment device for the skin using radio-frequency electric current
|
CA2933335A1
(en)
|
2013-12-11 |
2015-06-18 |
The General Hospital Corporation |
Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
|
US9421297B2
(en)
|
2014-04-02 |
2016-08-23 |
Adhezion Biomedical, Llc |
Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
|
WO2015200369A1
(en)
|
2014-06-24 |
2015-12-30 |
Neurogastrx, Inc. |
Prodrugs of metopimazine
|
NZ736131A
(en)
|
2014-09-26 |
2019-04-26 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
CA2967908C
(en)
|
2014-09-29 |
2020-11-17 |
Mahesh Kandula |
Compositions and methods for the treatment of multiple sclerosis
|
WO2016067297A1
(en)
|
2014-10-27 |
2016-05-06 |
Cellix Bio Private Limited |
Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
|
CA2965449C
(en)
|
2014-10-27 |
2020-11-10 |
Cellix Bio Private Limited |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
CN107207411A
(zh)
|
2014-12-01 |
2017-09-26 |
塞尔利克斯生物私人有限公司 |
用于治疗多发性硬化的组合物和方法
|
CA2976187A1
(en)
|
2015-02-09 |
2016-08-18 |
Cellix Bio Private Limited |
Benzydamine salts and compositions thereof useful for the treatment of mucositis
|
CA3011687A1
(en)
|
2015-02-16 |
2016-08-25 |
Zivo Bioscience, Inc. |
Methods of modulating immune and inflammatory responses via administration of an algal biomass
|
FR3034017B1
(fr)
|
2015-03-24 |
2018-11-02 |
Feeligreen |
Matrice polymerique adhesive pour iontophorese et dispositif pour l'iontophorese comprenant ladite matrice
|
WO2017142906A1
(en)
|
2016-02-16 |
2017-08-24 |
Zivo Bioscience, Inc. |
Nutritional support for animals via administration of an algal derived supplement
|
WO2017143345A1
(en)
|
2016-02-19 |
2017-08-24 |
Zp Opco, Inc. |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
|
MX2019001360A
(es)
|
2016-08-11 |
2019-06-03 |
Cellix Bio Private Ltd |
Composiciones y metodos para el tratamiento de sindrome de intestino irritable.
|
WO2018065831A1
(en)
|
2016-10-04 |
2018-04-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of xerostomia
|
NZ785293A
(en)
|
2016-11-28 |
2023-09-29 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of fungal infections
|
EP3554494A4
(de)
|
2016-12-19 |
2021-02-17 |
Cellixbio Private Limited |
Zusammensetzungen und verfahren zur behandlung von entzündungen
|
AU2018230478A1
(en)
|
2017-03-09 |
2019-09-12 |
Diamedica Inc. |
Dosage forms of tissue kallikrein 1
|
KR102340393B1
(ko)
|
2017-08-23 |
2021-12-17 |
조사노 파마 코포레이션 |
편두통 및 군발성 두통의 치료를 위한 졸미트립탄의 치료적 농도를 신속하게 달성하는 방법
|
US11660264B2
(en)
|
2017-08-23 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
TWI744848B
(zh)
|
2017-10-18 |
2021-11-01 |
英商核酸有限公司 |
包含具薄膜電晶體及電容感測之雙基板的數位微流體裝置
|
SG11202004019SA
(en)
|
2017-11-17 |
2020-05-28 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of eye disorders
|
CA3081482A1
(en)
|
2017-11-17 |
2019-05-23 |
Cellix Bio Private Limited |
Compounds, compositions and methods for treatment of eye disorders and skin diseases
|
US11660265B2
(en)
|
2018-06-28 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
US11724024B2
(en)
*
|
2018-07-24 |
2023-08-15 |
University Of Maryland, College Park |
Inverted battery devices, and systems and methods for use thereof
|
US11353759B2
(en)
|
2018-09-17 |
2022-06-07 |
Nuclera Nucleics Ltd. |
Backplanes with hexagonal and triangular electrodes
|
WO2020081478A1
(en)
*
|
2018-10-15 |
2020-04-23 |
E Ink Corporation |
Digital microfluidic delivery device
|
US10836757B1
(en)
|
2020-04-02 |
2020-11-17 |
Neurogastrx, Inc. |
Polymorphic forms of metopimazine
|
EP3922720A1
(de)
|
2020-06-09 |
2021-12-15 |
Universidad de Murcia |
Therapie zur verhinderung unerwünschter kardialer remodellierung nach einem akuten myokardinfarkt
|
WO2022147307A1
(en)
*
|
2020-12-30 |
2022-07-07 |
Georgia Tech Research Corporation |
Methods and devices for inducement of sweat for medical diagnostics
|
US20220265582A1
(en)
|
2021-02-24 |
2022-08-25 |
Universitätsspital Basel |
Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
|
US11801256B2
(en)
|
2021-06-08 |
2023-10-31 |
Universitätsspital Basel |
Antidepressant-psilocybin co-treatment to assist psychotherapy
|